Research ArticleArticle
D1-D2 Dopamine Receptor Synergy Promotes Calcium Signaling via Multiple Mechanisms
Lani S. Chun, R. Benjamin Free, Trevor B. Doyle, Xi-Ping Huang, Michele L. Rankin and David R. Sibley
Molecular Pharmacology August 2013, 84 (2) 190-200; DOI: https://doi.org/10.1124/mol.113.085175
Lani S. Chun
Molecular Neuropharmacology Section, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (L.S.C., R.B.F., T.B.D., M.L.R., D.R.S.); Cellular, Molecular, Developmental Biology & Biophysics Program, Johns Hopkins University, Baltimore, Maryland (L.S.C.); and National Institute of Mental Health Psychoactive Drug Screening Program, Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (X.-P.H.)
R. Benjamin Free
Molecular Neuropharmacology Section, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (L.S.C., R.B.F., T.B.D., M.L.R., D.R.S.); Cellular, Molecular, Developmental Biology & Biophysics Program, Johns Hopkins University, Baltimore, Maryland (L.S.C.); and National Institute of Mental Health Psychoactive Drug Screening Program, Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (X.-P.H.)
Trevor B. Doyle
Molecular Neuropharmacology Section, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (L.S.C., R.B.F., T.B.D., M.L.R., D.R.S.); Cellular, Molecular, Developmental Biology & Biophysics Program, Johns Hopkins University, Baltimore, Maryland (L.S.C.); and National Institute of Mental Health Psychoactive Drug Screening Program, Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (X.-P.H.)
Xi-Ping Huang
Molecular Neuropharmacology Section, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (L.S.C., R.B.F., T.B.D., M.L.R., D.R.S.); Cellular, Molecular, Developmental Biology & Biophysics Program, Johns Hopkins University, Baltimore, Maryland (L.S.C.); and National Institute of Mental Health Psychoactive Drug Screening Program, Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (X.-P.H.)
Michele L. Rankin
Molecular Neuropharmacology Section, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (L.S.C., R.B.F., T.B.D., M.L.R., D.R.S.); Cellular, Molecular, Developmental Biology & Biophysics Program, Johns Hopkins University, Baltimore, Maryland (L.S.C.); and National Institute of Mental Health Psychoactive Drug Screening Program, Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (X.-P.H.)
David R. Sibley
Molecular Neuropharmacology Section, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (L.S.C., R.B.F., T.B.D., M.L.R., D.R.S.); Cellular, Molecular, Developmental Biology & Biophysics Program, Johns Hopkins University, Baltimore, Maryland (L.S.C.); and National Institute of Mental Health Psychoactive Drug Screening Program, Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (X.-P.H.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
D1-D2 Receptor Synergy and Ca2+ Signaling
Lani S. Chun, R. Benjamin Free, Trevor B. Doyle, Xi-Ping Huang, Michele L. Rankin and David R. Sibley
Molecular Pharmacology August 1, 2013, 84 (2) 190-200; DOI: https://doi.org/10.1124/mol.113.085175
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement